Search by Drug Name or NDC
NDC 50090-5274-00 Desvenlafaxine 25 mg/1 Details
Desvenlafaxine 25 mg/1
Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is DESVENLAFAXINE SUCCINATE.
MedlinePlus Drug Summary
Desvenlafaxine is used to treat depression. Desvenlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance.
Related Packages: 50090-5274-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Desvenlafaxine
Product Information
| NDC | 50090-5274 |
|---|---|
| Product ID | 50090-5274_ac2b33e3-45e5-4061-a50f-5615a310d9a0 |
| Associated GPIs | |
| GCN Sequence Number | 073778 |
| GCN Sequence Number Description | desvenlafaxine succinate TAB ER 24H 25 MG ORAL |
| HIC3 | H7C |
| HIC3 Description | SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) |
| GCN | 38222 |
| HICL Sequence Number | 035420 |
| HICL Sequence Number Description | DESVENLAFAXINE SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Desvenlafaxine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Desvenlafaxine Succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | DESVENLAFAXINE SUCCINATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204003 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5274-00 (50090527400)
| NDC Package Code | 50090-5274-0 |
|---|---|
| Billing NDC | 50090527400 |
| Package | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5274-0) |
| Marketing Start Date | 2020-10-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |